Liver Protocol (6/27/2008 updated)

Overview

Liver MR imaging may be helpful in detecting and diagnosing lesions especially when other radiological studies are inconclusive. Small tumors and hepatic masses in a diffusely fatty liver may not be easily discerned on CT or US. In such cases, MR imaging may be the modality of choice. Indications include but are not limited to evaluation of parenchymal disease such as cirrhosis and hemosiderosis, characterization of suspected benign lesions such as hemangioma, FNH, and adenoma, and demonstration of dysplastic nodules or HCC in the cirrhotic liver. Donor liver volume and vascular anatomy prior to liver transplantation can be reliably demonstrated with 3D MR Angiography an optimally timed contrast-enhanced dynamic 3D gradient echo study (see reimbursable ICD9 codes).

Scheduling Guidelines

·        First Ask:

1.     Why is the liver MRI being requested?..................

2.     What prior liver imaging (CT, US) has been done? …………..If prior imaging was performed in another imaging center, please ask for a copy of report and ask patient to bring in films if possible.

3.      Have you had prior liver or gallbladder surgery? ………..…….. What operation? ………………

4.      Have you ever had cancer? ……….. What type of cancer? ………….…… When was the cancer diagnosed? ……………….

5.      Have you ever been diagnosed with any liver disease, such as hepatitis or cirrhosis? .............................

6.     What is the alpha fetoprotein level? ……LDH: ……SGPT: ….. SGOT: …… Alkaline Phosphatase: ……Total Bilirubin: ……

Patient Preparation

·        Start intravenous line (20 or 22 gauge IV). If iv caliber is small (i.e.  22 gauge) then warm the Gd contrast up to body temperature to reduce its viscosity.

·        Valium (5-10mg po) or Xanax (1-2 mg po) if patient is claustrophobic

·        Ear plugs

Coil: 8 channel body coil

Patient positioning: Supine, feet first. The arms are positioned comfortably next to abdomen. Patient must have comfortable pillow for head and a cushion under the knees to relieve back pressure.

Landmark: Three fingers below the xyphoid at rib cage margin. 

 

LIVER PROTOCOLS

 

 

3-plane

Localizer

ASSET Calibration

SSFSE Coronal

SSFSE Axial

Axl T2 FSAT BH

Axl In Phase

Axl Out of phase

Axl LAVA 5phase

COR LAVA Delayed

Axl LAVA 90 MIN (optional)

 

Coil

8Cardiac

 

 

 

8Cardiac

8Cardiac

8Cardiac

8Cardiac

8Cardiac

8Cardiac

 

IMAGING PARAMETERS

 

Plane

3-Plane

Axial

Coronal

Axial

Axial

Axial

Axial

Axial

Coronal

Axial

 

Mode

2D

Calib

2D

2D

2D

2D

2D

3D

3D

3D

 

Pulse Sequence

Spin-Echo

Fast GRE

Spin Echo

Spin Echo

FRFSE-XL

SPGR

SPGR

LAVA

LAVA

LAVA

 

Imaging Options

 

Seq, Fast, SS

Calib,Fast

Fast, ZIP512, SS

Fast, ZIP512, SS

FC,TRF,Fast,

ZIP512,FR

EDR, Fast,

ZIP512

EDR, Fast, ZIP512

EDR,Fast, ZIP512

EDR,Fast,

ZIP512,ZIP2

EDR,Fast, ZIP2

 

SCAN TIMING

 

# of TE

1

 

1

1

1

1

1

1

1

1

 

TE

 102

 

180

90

 100

In phase

Out of phase

 

 

 

 

TR

 

 

Minimum

Minimum

2110.0

 200.0

 200.0

 

 

 

 

Flip Angle

 

 

 

 

 

90

90

12

12

12

 

Bandwidth

 83 kHz

 

31.25

31.25

31.25

31.25

31.25

62.50

62.50

62.50

 

ETL

 

 

 

 

 17

 

 

 

 

 

 

BSP TI

 

 

 

 

 

 

 

 

 

 

 

Prep Time

 

 

 

 

 

 

 

 

 

 

 

ADDITIONAL PARAMETERS (see attached instructions)

 

SAT

 

 

 

 

 

 

 

F:sp

 F:sp

 

 

Multiphase

 

 

 

 

 

 

 

 

 

4-phases, Mask phase, pause after mask, auto subtract 

 

 

 

ACQUISITION TIMING

 

Freq

256

 

256

256

256

256

256

320

320

320

 

Phase

128

 

192-256

192

160

160

160

192

192

192

 

NEX

 

 

 

 

1

1

1

 

 

 

 

Phase FOV

 1.00

 

1

1.00

0.75

0.75

0.75

0.80

0.80

0.80

 

# locs Bef Pause

 0

 

10

0

 

 

0

 

0

 

 

Freq DIR

 unswap

R/L

S/I

R/L

R/L

R/L

R/L

R/L

S/I

R/L

 

Auto Cent Freq

 

 

 

 

 

 

 

 

 

 

 

Shim

 Auto

Auto

Auto

Auto

Auto

Auto

Auto

Auto

Auto

 Auto

 

Phase Correct

 

 

Yes

 

 Yes

 

 

 

 

 

 

Contrast

 

 

 

 

 

No

 

 

 

 

 

SCANNING RANGE

 

FOV

48

48

44

32.0

40

38

38

36

36

36

 

Slice Thickness

10

13

8

8

8

8.0

8.0

6

6

6.0

 

Spacing

5

 

0

2.0

1.0

 2.0

 2.0

# of scan locs = 32

# of scan locs = 32

# of scan locs = 32

 

Start - End

Center = 0

I300-S300

A80-P70

0

0

 

 

 

 

 

 

# Slices

9/plane

48

20

 

 

 

 

 

 

 

 

Locs per slab

 

 

 

 

 

 

 

 

 

 

 

Scan Time

0:22

0:13

0:29

0:00.74

0:21

0:26

0:26

5:09 (0:23)

0:23

0:23

 

Series 1: 3-plane localizer

This is a quick localizer sequence obtained in three planes which is used to confirm optimal patient positioning.

Series 2: ASSET Calibration

Array spatial sensitivity encoding technique (ASSET) is a parallel imaging technique which uses independent signals from each of the coil elements to accelerate data acquisition. Prior to image acquisition with ASSET, a single breath-hold low-resolution reference scan (ASSET calibration) must be run to obtain a sensitivity map for each coil in the phased array for calculating the missing k-space data. These sensitivity maps are needed to unwrap the aliasing in the ASSET scan. ASSET calibration FOV is set to 48 cm and should be prescribed from the top of the coil to the bottom of the coil.

Series 3: Coronal SSFSE (single-shot fast spin-echo)

·        This sequence is ready to go. If you do not want to run 3-plane localizer, and ASSET calibration, just hit the “scan” button.

·        This sequence is performed in inspiration as a guide for prescribing breath hold scans. In really large patients (large in the AP dimension), it may be useful to cover more anteriorly. When acquiring the coronal scan, use the 8 channel body coil full FOV.

Series 4: Axial SSFSE

·        SSFSE sequence has some advantages over other T2 weighted imaging techniques; high SNR due to the reduced noise from ghost artifacts, less respiratory motion artifact, and higher patient cooperation compared to the long acquisition techniques. High CNR increases the lesion detection especially for non-solid lesions.

·        In SSFSE, a single 90° excitation pulse is followed by sufficient 180° pulses and readouts to encode half of k-space. This sequence is very RF intensive; to avoid from exceeding the specific absorption rate (SAR) limits, a refocusing flip angle of 130° may be preferred especially at 3T rather than the usual value of 180°.

·        Slice acquisition order can be either interleaved or sequential. If you do not select sequential order, the interleaved technique is used. When sequential is used, the SNR and image contrast can decrease due to cross talk.

·        Scan from top of liver to bottom of liver with breath hold (if possible).

·        User CV: Fractional NEX optimization: if it is “on”, SNR and T2 weighting increase. If it is “off” the scan time is shorter.

·        Maximum number of echoes is set to 260 (largest possible value). This improves image quality (SNR) at the expense of time.

·        If you increase the bandwidth, image blurring may be decreased at the expense of SNR.

·        Switch 8 channel body array coil to “upper”.

Series 5: Axial dual in-phase and out-of phase

The purpose of using dual-phase chemical-shift imaging is to detect lipid either in hepatic parenchyma or within hepatocellular neoplasms. This is a non-enhanced breath-hold T1-weighted spoiled gradient-echo (SPGR) sequence in which periodic chemically selective fat-saturation pulses have been incorporated. Short TRs and short TEs are used. When TE is in phase (4.2 ms at 1.5 T), fat and water signals combine (in-phase imaging). Out-of-phase imaging is performed with a TE of 2.1 ms at 1.5 T. Fat will lose signal intensity on out-of phase images, because the signals from fat and water protons cancel each other. This sequence is also helpful to look for iron deposition in liver parenchyma. In patients with iron accumulation, parenchymal signal is lower on the longer TE in-phase images.

·        Select 2 echoes, system automatically acquires in and out-of-phase images.

·        User CV: Select turbo mode before entering the matrix values. Turbo mode reduces the RF pulse width and therefore shortens the TR. As the turbo mode gets faster, tissue contrast decreases but vessel-background contrast increases.

·        Scan from top of liver to bottom of liver. Breath-holding is critical. Repeat as necessary for optimum image quality.

Series 6: Axial 3D Dynamic Gd (FAME)

On older scanners this was performed as out-of-phase 2D FMPSPGR with fat saturation to eliminate artifact at fat-organ boundaries. On state-of-art scanners, 3D provides higher resolution and allows zero filling (ZIP2) for overlapping reconstruction of slices. Repeat the scan multiple times with breath holding as follows:

·        Pre-contrast fat-saturated 3D volume images are obtained. These provide T1-weighted information.

·        Begin to administer 0.1-0.2 mmol/kg dose of Gd contrast (typically 30 ml) at a rate of 3 ml/s, and set the fluoro-triggering to detect to contrast arrival. Operator may visually follow the contrast travel through the right heart, pulmonary arteries, ascending aorta and finally descending aorta. Triggering the scan should be done when the contrast arrives to proximal segment of abdominal aorta (diaphragmatic level). As soon as the operator observes the contrast arrival, instructs the patient to hold his/her breath at the end of inspiration, and triggers the sequence. There is a 5 s delay between triggering and the beginning of actual acquisition for breathe holding instructions.

·        Gd injection is followed by 20 ml of saline flush at a rate of 3 ml/s.

·        The first acquisition is timed for arterial enhancement. Same acquisition is performed subsequently multiple times in quick succession (10 seconds between each to allow patients to catch their breath) to acquire the portal, hepatic venous, and equilibrium phases. The scan may be repeated as much as desired. Delayed phase imaging: If the liver is cirrhotic, a delay of 3 minutes is adequate. If there is a suspicious lesion that might be hemangioma or cholangiocarcinoma, then repeat scan every 2-3 minutes out to 10 minutes. Cholangiocarcinoma is known to enhance late.

·        A chemically selective fat-saturation pulse is applied just before each partitions loop. In the saturation pulse area, choose the ‘special’. The partitions loop is centric reordered to optimize fat-saturation uniformity.

·        Zero-filling interpolation can reduce partial volume artifacts on 3D MR angiograms.

·        The 3D volumetric imaging technique is a modified MRA sequence. The operator, by using “IVI” option and MIP algorithms on the scanner or Windows Advantage work station can obtain reconstructions of the arterial territories.

Series 7: Post-Gd Coronal T1

The late phase delayed 2D sequence is performed using fat saturation. This includes abdomen and pelvis and should be performed with the coil set to full FOV.

Series 8: Fast 2D TOF

This sequence is performed when the study is ordered for liver donor. It produces excellent vascular motion suppression with respiratory compensation (ROPE) which is especially useful in patients who cannot breathe hold.

 

Billing Instructions

 

Reimbursable ICD9 Codes

570

Acute and subacute necrosis of liver

571

Chronic liver disease and cirrhosis

 

571.0

Alcoholic fatty liver

 

571.2

Alcoholic cirrhosis of liver

 

571.3

Alcoholic liver damage, unspecified

 

571.4

Chronic hepatitis

 

571.5

Cirrhosis of liver without mention of alcohol

 

571.6

Biliary cirrhosis

 

571.8

Other chronic nonalcoholic liver disease

 

571.9

Unspecified chronic liver disease without mention of alcohol

572

Liver abscess and sequelae of chronic liver disease

 

572.0

Abscess of liver

 

572.3

Portal hypertension

 

572.8

Other sequelae of chronic liver disease

573

Other disorders of liver

 

573.0

Chronic passive congestion of the liver

 

573.1

Hepatitis in viral diseases classified elsewhere

 

573.2

Hepatitis in other infectious diseases classified elsewhere

 

573.3

Hepatitis, unspecified

 

573.4

Hepatic infarction

 

573.9

Unspecified disorder of liver

155.0

Primary malign neoplasm

155.1

Malign neoplasm of intrahepatic bile ducts

155.2

Liver, not specified as primary or secondary

211.5

Benign neoplasm

228.0

Hemangioma

239

Unspecified

197.7

Metastasis

789

Hepatomegaly

751.6

Congenital anomalies of liver

V42.7

Transplanted Liver

V59.6  

Liver Donor

195.2

Malignant Neoplasm of Abdomen    

 

Normal Liver Dictation Template

 Clinical Statement:

Technique: 1.5 Tesla, phased array, coronal and axial SSFSE, axial in-and out-of-phase spoiled gradient echo, 3D dynamic Gd-enhanced (FAME) and post-Gd fat suppressed coronal T1 sequences.

Findings:

          Ascites: No ascites

Liver: The liver is normal in size, contour and has normal signal intensity on all sequences. No focal hepatic lesions are identified.

Portal Vein: Widely patent

Hepatic Veins: Widely patent

Biliary: No dilatation

Gall Bladder: Normal in size and configuration, no cholelithiasis, no inflammation

Spleen: Normal size and signal, no focal lesions

Pancreas: Normal in size and contour, normal signal intensity on all sequences, no focal lesions are identified.

Adrenal Glands: No masses identified
Right Kidney: Normal in size, contour, signal intensity. No pelvicaliceal dilatation, no masses.

Left Kidney: Normal in size, contour, signal intensity. No pelvicaliceal dilatation, no masses.

Retroperitoneum: No adenopathy

Impression: Normal MR of liver; no lesion identified.

Liver Hemangioma Dictation

Technique: 1.5 T, phased array coil, coronal and axial SSFSE, axial dual echo SPGR, 3D dynamic Gd-enhanced (FAME) and post-Gd fat suppressed coronal T1 sequences. 

Findings:  A…. x…. cm lesion is identified in the …….. lobe of the liver (segment #). It is T1 dark, homogeneously T2 bright with smooth margins and enhances with Gd initially with peripheral puddling which gradually progresses to homogeneous enhancement which persist on delayed images. There is no lesion suspicious for metastasis or malignancy. The liver size, contour and signal intensity are normal. The portal vein and hepatic veins are widely patent. There is no biliary dilation.

The pancreas, spleen, adrenal glands and kidneys are normal. No retroperitoneal lymphadenopathy is identified.

Impression: ….. x …. cm hemangioma in …….. lobe (segment….) of liver; otherwise normal abdominal MRI findings.